Entry |
|
Name |
Pyrazinamide;
Pyrazinoic acid amide
|
Formula |
C5H5N3O
|
Exact mass |
123.0433
|
Mol weight |
123.1127
|
Structure |
|
Remark |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J04 ANTIMYCOBACTERIALS
J04A DRUGS FOR TREATMENT OF TUBERCULOSIS
J04AK Other drugs for treatment of tuberculosis
J04AK01 Pyrazinamide
D00144 Pyrazinamide (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Antimycobacterials
Antituberculars
Pyrazinamide
D00144 Pyrazinamide (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
622 Tuberculosis preparations
6223 Pyrazinamides
D00144 Pyrazinamide (JP18/USP/INN)
Drug groups [BR:br08330]
Antibacterial
DG01966 Antitubercular
DG02009 Pyrazinamide derivative
D00144 Pyrazinamide
Antimicrobials [BR:br08307]
Antibacterials
Bactericidal action
Pyrazinamide
D00144 Pyrazinamide (JP18/USP/INN) <JP/US>
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Bactericidal action
Pyrazinamide
D00144 Pyrazinamide (JP17/USP/INN)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00144 Pyrazinamide
Prodrugs [br08324.html]
D00144
Prodrugs [br08324.html]
C01956
|
Other DBs |
|
KCF data |
ATOM 9
1 C8y C 16.5851 -14.5401
2 C8x C 16.5851 -15.9475
3 N5x N 15.3632 -13.8427
4 C5a C 17.7880 -13.8427
5 N5x N 15.3632 -16.6577
6 C8x C 14.1604 -14.5401
7 N1a N 18.9971 -14.5336
8 O5a O 17.7880 -12.5180
9 C8x C 14.1604 -15.9475
BOND 9
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 2
6 4 7 1
7 4 8 2
8 5 9 2
9 6 9 1
|